查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947822

空間基因組學和轉錄組學市場分析及預測（至2035年）：按類型、產品類型、服務、技術、應用、最終用戶、組件、流程、功能分類

Spatial Genomics and Transcriptomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Functionality
出版日期: | 出版商: Global Insight Services | 英文 359 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計空間基因組學和轉錄組學市場將從2024年的5.825億美元成長到2034年的14.235億美元，複合年成長率約為10.4%。該市場涵蓋了在組織空間背景下繪製基因活性和表達圖譜的技術。這些解決方案能夠揭示細胞異質性和組織結構，這對理解複雜的生物學過程至關重要。影像、定序和數據分析技術的進步正在推動這個市場的發展，為疾病機制和治療標靶的研究提供了新的視角，其應用領域涵蓋腫瘤學、神經科學和發育生物學。

空間基因組學和轉錄組學市場正經歷強勁成長，這主要得益於單細胞分析和空間解析度技術的進步。耗材領域成長率最高，主要得益於空間分析工作流程中必需的試劑和試劑盒的日益普及。其次是儀器領域，影像系統和定序平台的出現增強了資料擷取能力。在耗材領域，試劑子領域佔據主導地位，這反映了其在實現精確空間分析方面的重要作用。針對特定研究需求的標靶檢測試劑盒正迅速崛起，成為第二大成長點。在儀器領域，空間成像系統憑藉其對細胞環境的高解析度分析能力而處於主導。支援全面轉錄組分析的定序平台是第二大成長驅動力。此外，市場還受到對能夠提高工作流程效率和數據準確性的整合解決方案的需求不斷成長的推動。人們對多組體學方法的日益關注正在促進整個行業的創新與合作，為研發領域創造新的機會。

市場區隔
類型 空間基因組學，空間轉錄組學
產品 設備、耗材和軟體
服務 樣品製備、數據分析、諮詢
科技 基於成像、定序定序
應用領域 癌症研究、神經科學、免疫學、藥物發現、發育生物學
最終用戶 學術和研究機構、製藥和生物技術公司、醫院和診所
成分 硬體、軟體和服務
過程 單細胞分析、組織層次分析
功能 數據視覺化、資料整合

空間基因組學和轉錄組學市場正經歷動態變化，創新的定價策略和新產品的推出導致市場佔有率不斷轉移。各公司正利用先進技術提升產品和服務，並專注於準確性和擴充性。競爭格局的特點是不斷湧現新的解決方案，以滿足日益成長的對高空間解析度和全面轉錄組分析的需求。市場擁有強大的產品線，反映出各公司致力於滿足基因組研究不斷變化的需求。空間基因組學和轉錄組學市場的競爭異常激烈，主要參與者透過策略聯盟和技術創新爭奪主導。監管影響，尤其是在北美和歐洲，在確保合規性和標準化以及塑造市場動態發揮關鍵作用。腫瘤學、神經病學和發育生物學等多元化的應用領域進一步豐富了市場，促進了這些技術的應用。隨著監管環境的不斷變化，各公司也在不斷調整以確保合規性，從而增強自身競爭優勢並推動市場成長。

主要趨勢和促進因素：

空間基因組學和轉錄組學市場正經歷強勁成長，這主要得益於單細胞分析技術的進步。這些創新使研究人員能夠以前所未有的精準度探索細胞異質性。一個關鍵趨勢是將空間資訊與基因組數據結合，從而深入了解組織結構和細胞間相互作用。這種整合正在徹底改變我們對複雜生物系統和疾病機制的理解。另一個關鍵促進因素是對個人化醫療日益成長的需求。隨著醫學朝著個人化治療方法發展，空間基因組學和轉錄組學為制定治療策略提供了至關重要的數據。研究人員和臨床醫生正在利用這些技術，透過生物標記識別和標靶治療來改善患者的治療效果。學術機構和生物技術公司之間日益密切的合作也透過加速研發推動了市場成長。此外，空間基因體學在藥物發現領域的應用也值得關注。製藥公司正在利用這些技術來識別新的藥物靶點，並在細胞層面上闡明藥物的作用機制。預計這種應用將縮短藥物研發的時間並降低成本。此外，政府和私人機構對生命科學研究的投入不斷增加，促進了太空基因組學和轉錄組學技術在各個領域的廣泛應用。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 空間基因體學
    • 空間轉錄組學
  • 市場規模及預測：依產品分類
    • 裝置
    • 消耗品
    • 軟體
  • 市場規模及預測：依服務分類
    • 樣品製備
    • 數據分析
    • 諮詢
  • 市場規模及預測：依技術分類
    • 成像基地
    • 定序定序
  • 市場規模及預測：依應用領域分類
    • 癌症研究
    • 神經科學
    • 免疫學
    • 藥物發現
    • 發育生物學
  • 市場規模及預測：依最終用戶分類
    • 學術和研究機構
    • 製藥和生物技術公司
    • 醫院和診所
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
  • 市場規模及預測：依製程分類
    • 單細胞分析
    • 組織層級分析
  • 市場規模及預測：依功能分類
    • 數據視覺化
    • 資料整合

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • 10x Genomics
  • Nano String Technologies
  • Akoya Biosciences
  • Vizgen
  • Resolve Biosciences
  • Spatial Transcriptomics AB
  • Bio-Techne
  • Ultivue
  • Rebus Biosystems
  • Rare Cyte
  • Advanced Cell Diagnostics
  • Canopy Biosciences
  • Genomic Vision
  • CARTANA
  • Celsee
  • Kroma Ti D
  • Hyb & Seq Technologies
  • Read Coor
  • Molecular Instruments
  • Quantapore

第9章：關於我們

簡介目錄
Product Code: GIS325701

Spatial Genomics and Transcriptomics Market is anticipated to expand from $582.5 million in 2024 to $1,423.5 million by 2034, growing at a CAGR of approximately 10.4%. The Spatial Genomics and Transcriptomics Market encompasses technologies that map gene activity and expression within the spatial context of tissues. These solutions reveal cellular heterogeneity and tissue architecture, crucial for understanding complex biological processes. Advancements in imaging, sequencing, and data analysis drive this market, offering insights into disease mechanisms and therapeutic targets, with applications spanning oncology, neuroscience, and developmental biology.

The Spatial Genomics and Transcriptomics Market is experiencing robust growth, fueled by advancements in single-cell analysis and spatial resolution technologies. The consumables segment is the top performer, driven by increased adoption of reagents and kits essential for spatial analysis workflows. Instruments follow closely, with imaging systems and sequencing platforms enhancing data acquisition capabilities. Within consumables, the reagents sub-segment outpaces others, reflecting their critical role in enabling precise spatial profiling. Kits for targeted assays are emerging as a strong second, catering to specific research needs. In instruments, spatial imaging systems lead, offering high-resolution insights into cellular environments. Sequencing platforms are gaining momentum as the second-highest performers, supporting comprehensive transcriptomic analysis. The market is further bolstered by the rising demand for integrated solutions that streamline workflows and improve data accuracy. Growing interest in multi-omics approaches is driving innovation and collaboration across the sector, unlocking new opportunities for research and development.

Market Segmentation
TypeSpatial Genomics, Spatial Transcriptomics
ProductInstruments, Consumables, Software
ServicesSample Preparation, Data Analysis, Consulting
TechnologyImaging-Based, Sequencing-Based
ApplicationCancer Research, Neuroscience, Immunology, Drug Discovery, Developmental Biology
End UserAcademic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics
ComponentHardware, Software, Services
ProcessSingle-Cell Analysis, Tissue-Level Analysis
FunctionalityData Visualization, Data Integration

The Spatial Genomics and Transcriptomics Market is experiencing a dynamic shift, with market share being influenced by innovative pricing strategies and the introduction of new products. Companies are leveraging advanced technologies to enhance their offerings, focusing on precision and scalability. The competitive landscape is marked by the emergence of novel solutions that cater to the increasing demand for detailed spatial resolution and comprehensive transcriptomic profiling. This market is characterized by a robust pipeline of product launches, reflecting a commitment to addressing the evolving needs of genomic research. Competition in the Spatial Genomics and Transcriptomics Market is intense, with key players vying for dominance through strategic alliances and technological advancements. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, ensuring compliance and standardization. The market is further enriched by a diverse range of applications spanning oncology, neurology, and developmental biology, driving the adoption of these technologies. As the regulatory landscape evolves, companies are adapting to ensure alignment, thereby enhancing their competitive edge and fostering market growth.

Geographical Overview:

The Spatial Genomics and Transcriptomics Market is witnessing dynamic growth across various global regions, each presenting unique opportunities. North America leads with substantial research funding and advanced healthcare infrastructure. The region's focus on precision medicine and genomics propels market expansion. Europe follows, driven by robust academic research and government initiatives supporting genomics. The emphasis on personalized healthcare solutions enhances market potential. In Asia Pacific, the market is rapidly expanding due to technological advancements and rising healthcare investments. Countries like China and India are emerging as key players, supported by government initiatives and increasing genomic research. Latin America and the Middle East & Africa are burgeoning markets with untapped potential. In Latin America, rising healthcare expenditure and genomic research investments are notable. Meanwhile, the Middle East & Africa recognize the significance of genomics in healthcare innovation, driving market interest and development. These regions represent promising growth pockets for the industry.

The Spatial Genomics and Transcriptomics Market is navigating complex global tariffs and geopolitical risks, particularly in East Asia. Japan and South Korea are mitigating tariff impacts by fostering innovation in spatial analysis technologies, while China accelerates domestic capabilities amid export restrictions. Taiwan, pivotal in semiconductor supply, faces geopolitical vulnerabilities due to US-China tensions. The broader genomics market is robust, driven by advancements in personalized medicine and bioinformatics. By 2035, the market is expected to flourish, contingent on resilient supply chains and strategic collaborations. Middle East conflicts may exacerbate global supply chain disruptions and elevate energy prices, influencing production costs and timelines. East Asian strategies increasingly focus on self-reliance and regional partnerships to navigate trade tensions and ensure market stability.

Key Trends and Drivers:

The Spatial Genomics and Transcriptomics Market is experiencing robust growth, fueled by advancements in single-cell analysis technologies. These innovations are enabling researchers to explore cellular heterogeneity with unprecedented precision. A key trend is the integration of spatial information with genomic data, offering insights into tissue architecture and cellular interactions. This integration is revolutionizing our understanding of complex biological systems and disease mechanisms. Another significant driver is the increasing demand for personalized medicine. As healthcare moves towards tailored therapeutic approaches, spatial genomics and transcriptomics provide critical data that inform treatment strategies. Researchers and clinicians are leveraging these technologies to identify biomarkers and develop targeted therapies, enhancing patient outcomes. The rise of collaborations between academic institutions and biotechnology companies is also propelling market growth by accelerating research and development efforts. Moreover, the expanding application of spatial genomics in drug discovery is noteworthy. Pharmaceutical companies are utilizing these technologies to identify novel drug targets and understand drug mechanisms at a cellular level. This application is expected to reduce drug development timelines and costs. Additionally, the growing investment in life sciences research, supported by governmental and private funding, is facilitating the adoption of spatial genomics and transcriptomics technologies across various sectors.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Spatial Genomics
    • 4.1.2 Spatial Transcriptomics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Consumables
    • 4.2.3 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sample Preparation
    • 4.3.2 Data Analysis
    • 4.3.3 Consulting
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Imaging-Based
    • 4.4.2 Sequencing-Based
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Cancer Research
    • 4.5.2 Neuroscience
    • 4.5.3 Immunology
    • 4.5.4 Drug Discovery
    • 4.5.5 Developmental Biology
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Academic & Research Institutions
    • 4.6.2 Pharmaceutical & Biotechnology Companies
    • 4.6.3 Hospitals & Clinics
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Single-Cell Analysis
    • 4.8.2 Tissue-Level Analysis
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Visualization
    • 4.9.2 Data Integration

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 10x Genomics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Nano String Technologies
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Akoya Biosciences
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Vizgen
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Resolve Biosciences
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Spatial Transcriptomics AB
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Bio- Techne
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ultivue
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Rebus Biosystems
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Rare Cyte
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Advanced Cell Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Canopy Biosciences
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Genomic Vision
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 CARTANA
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Celsee
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Kroma Ti D
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Hyb & Seq Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Read Coor
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Molecular Instruments
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Quantapore
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us